tiprankstipranks
Trending News
More News >
BICO Group AB Class B (SE:BICO)
:BICO
Sweden Market
Advertisement

BICO Group AB Class B (BICO) Earnings Dates, Call Summary & Reports

Compare
3 Followers

Earnings Data

Report Date
Feb 18, 2026
TBA (Confirmed)
Period Ending
2025 (Q4)
Consensus EPS Forecast
-0.11
Last Year’s EPS
3.65
Same Quarter Last Year
Based on 0 Analysts Ratings

Earnings Call Summary

Q3 2025
Earnings Call Date:Nov 04, 2025|
% Change Since:
|
Earnings Call Sentiment|Neutral
The earnings call presents a mixed picture with strong growth in Lab Automation and significant orders from a global pharma company. However, impairments and macroeconomic challenges, including negative cash flow from operations, present notable challenges.
Company Guidance
During the BICO Group's Q3 2025 earnings call, CEO Maria Forss and CFO Jacob Thordenberg provided detailed guidance on the company's financial performance and strategic direction. BICO reported a net sales of SEK 387 million, marking a 12% organic sales growth despite macroeconomic challenges. The Life Science Solutions sector experienced a 4% organic sales growth, driven by diagnostics and demand for Lab Automation components, while Lab Automation rebounded with a 35% organic sales growth. Financial highlights included an adjusted EBITDA of SEK 17 million, reflecting a 5% margin improvement attributed to cost control and operational efficiencies. The call also noted significant orders totaling USD 15.2 million from a global pharma company and the divestment of MatTek and Visikol, which strengthened BICO's cash position by SEK 740 million. Long-term growth expectations are set at around 10% CAGR for Discover ECHO and Biosero, supported by ongoing R&D investments and product innovations within lab automation solutions.
Strong Lab Automation Growth
Lab Automation delivered 35% organic sales growth, rebounding after an abnormal Q2. This showcases strong underlying demand and successful execution of the action plan to enhance processes and capabilities.
Significant Orders from Global Pharma
Biosero received orders worth USD 15.2 million from a global pharma company, indicating strong demand for Lab Automation solutions and the market-leading Green Button Go software suite.
Cash Position Strengthening
The divestments of MatTek and Visikol generated SEK 740 million, significantly strengthening BICO's cash position and resulting in a positive net cash position.
Improved EBITDA Margin
Adjusted EBITDA amounted to SEK 17 million, with a margin of 5%, reflecting improved cost control and operational efficiencies.

BICO Group AB Class B (SE:BICO) Earnings, Revenues Date & History

The upcoming earnings date is based on a company’s previous reporting, and may be updated when the actual date is announced

SE:BICO Earnings History

Report Date
Fiscal Quarter
Forecast / EPS
Last Year's EPS
EPS YoY Change
Press Release
Slides
Play Transcript
Feb 18, 2026
2025 (Q4)
-0.11 / -
3.65
Nov 04, 2025
2025 (Q3)
-1.02 / -15.51
-3.625-327.72% (-11.88)
Aug 19, 2025
2025 (Q2)
-1.20 / -2.50
-1.07-133.64% (-1.43)
Apr 29, 2025
2025 (Q1)
-1.23 / -3.28
-0.405-709.88% (-2.88)
Feb 19, 2025
2024 (Q4)
-0.23 / 3.65
-8.495142.97% (+12.14)
Nov 26, 2024
2024 (Q3)
-0.43 / -3.63
-0.98-269.90% (-2.65)
Aug 20, 2024
2024 (Q2)
-0.95 / -1.07
-7.92586.50% (+6.85)
May 07, 2024
2024 (Q1)
-0.75 / -0.41
-1.67575.82% (+1.27)
Feb 20, 2024
2023 (Q4)
-0.04 / -8.49
-8.445-0.59% (-0.05)
Nov 14, 2023
2023 (Q3)
-0.81 / -0.98
1.055-192.89% (-2.04)
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed

SE:BICO Earnings-Related Price Changes

Report Date
Price 1 Day Before
Price 1 Day After
Percentage Change
Nov 04, 2025
kr21.00kr23.90+13.81%
Aug 19, 2025
kr34.94kr27.00-22.72%
Apr 29, 2025
kr39.42kr36.70-6.90%
Feb 19, 2025
kr37.50kr44.12+17.65%
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.

FAQ

When does BICO Group AB Class B (SE:BICO) report earnings?
BICO Group AB Class B (SE:BICO) is schdueled to report earning on Feb 18, 2026, TBA (Confirmed).
    What is BICO Group AB Class B (SE:BICO) earnings time?
    BICO Group AB Class B (SE:BICO) earnings time is at Feb 18, 2026, TBA (Confirmed).
      Where can I see when companies are reporting earnings?
      You can see which companies are reporting today on our designated earnings calendar.
        What companies are reporting earnings today?
        You can see a list of the companies which are reporting today on TipRanks earnings calendar.
          What is the P/E ratio of BICO Group AB Class B stock?
          The P/E ratio of BICO Group AB Class B is N/A.
            What is SE:BICO EPS forecast?
            SE:BICO EPS forecast for the fiscal quarter 2025 (Q4) is -0.11.
              What am I Missing?
              Make informed decisions based on Top Analysts' activity
              Know what industry insiders are buying
              Get actionable alerts from top Wall Street Analysts
              Find out before anyone else which stock is going to shoot up
              Get powerful stock screeners & detailed portfolio analysis